Senior Analyst - Forecasting

Essential Skills/Experience:

• Bachelor’s Degree or equivalent experience in relevant field
• 6+ years of direct Pharmaceutical forecasting experience with an in-depth knowledge of forecasting techniques, models and approaches
• Good understanding of multiple disease areas, with experience in rare diseases/ OBU including how patients move through their respective diagnosis and treatment pathways, including treatment dynamics
• Experience integrating insights from market studies and existing data analysis into forecast assumptions
• Experience using various data sources and analytics involving standard data in the Pharmaceutical industry – e.g. IQVIA (MIDAS, DDD NPA, Monthly Xponent), claims data (Truven, Marketscan), epidemiological data, etc. For US forecasting, experience with TRx / NBRx / NRx data and methodologies
• Strong analytical expertise; excellent Excel, financial modelling and forecasting skills
• Ability to build positive relationships across various partner groups including Marketing, Analytics, Operations, and Technology
• Validated experience in problem solving and continuous improvement
• Strong written and verbal communication

Desirable Skills/Experience:

• Advanced degree or equivalent experience preferred (e.g., PhD, MBA, Masters)
• Knowledge and experience in sophisticated statistical forecast methodologies and applied AI / ML / automation
• Experience working with Power Apps, specifically PowerBI
• For US forecasting, validated understanding of US Market Access and gross-to-net
• When we put unexpected teams in the same room, we fuel bold thinking with the power to encourage life-changing medicines. In-person working gives us the platform we need to connect, work at pace and challenge perceptions. That's why we work, on average, a minimum of three days per week from the office. But that doesn't mean we're not flexible. We balance the expectation of being in the office while respecting individual flexibility. Join us in our outstanding and high-reaching world.

Why AstraZeneca:

Call to Action:

Closing Date